|
Medtronic received information that prior to the implant of this transcatheter bioprosthetic pulmonary valve, the pre-case analysis indicated the difficulty level of the implant procedure due to the single 1mm implant landing zone and complex patient anatomy.During the attempted implant, the right pulmonary artery wire position was used.During deployment, it was noted that with struts 1 and 2 deployed high in the main pulmonary artery (mpa) at bifurcation and at recommended landing zone, the valve dropped down into the mpa when attempting to deployed struts 3-6.Subsequently, the valve deployment was unsuccessful due to the complex patient anatomy with 1mm landing zone and inability to maintain necessary high implant position.An attempt was made to use the dcs to resheathed the valve but was not successful.Multiple attempts to advance the 26f non-medtronic sheath into the mpa to sheath the partially deployed valve were made without success.In addition, the partially deployed valve (struts 1 and 2 unsheathed) was then pulled through tricuspid valve and then sheathed into the non-medtronic sheath at the inferior vena cava level.The valve was resheathed due to low anatomical position.A pyramidal type anatomy with large proximal pulmonary artery/right ventricular outflow tract (rvot) with 1mm landing zone and tortuous right ventricle to rvot contributed to the deployment issue.Following the procedure, the physician concluded that the valve moved into a low position due to not maintaining forward pressure on the dcs while unsheathing struts 3-6.The implanting physician chose not to re-attempt the implant but to plan a pulmonary valve implant at a later date.No adverse patient effects were reported.
|
|
This regulatory report is being submitted due to retrospective review through capa 624392.Section d references the main component of the system.Other medical products in use during the event include: product id harmony-25 (serial:(b)(6) ; product type: 0195-heart valves; implant date n/a; explant date n/a conclusion: intra procedural fluoroscopic images were provided for review of the event.The images appear to show a partly deployed valve rows 1 and 2.In the lateral projection initially rows 1 and partially row 2 showed proper deployment and then as row 2 completely unsheathed then a possibly misalignment within the anatomy.Various potential factors that can influence difficulty positioning the valve include substantial variability within the native rvot space, the anatomy landmark visibility can be challenging due to imaging angles, large anatomical variation between patients regarding size and morphology and several others.Per the ifu, ¿during deployment, the dcs can be advanced or withdrawn prior to the outflow struts protruding from the capsule.Once the tpv struts contact the anatomy during deployment, it is not recommended to reposition the device.Advancing the catheter forward once the tpv struts make contact with the anatomy may lead to an undesired deployment or may cause damage to or failure of the tpv and injury to the patient¿.Historically, high forces in the system may result in difficulty deploying the valve.The force in the system is a cumulative effect that can be increased by many other factors, including bends and kinks on the shaft, tortuous anatomy and guidewire and sheath selection.In this case the physician concluded that the valve moved into a low position due to not maintaining forward pressure on the dcs while unsheathing struts 3-6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|